New Hampshire's abortion restrictions

Article

We spoke with Editorial Board member Ilana Cass, MD, about her opinion of her state's latest abortion restrictions.

The Fetal Life Protection Act was part of a $13.5 billion budget bill in New Hampshire. Gov. Chris Sununu signed "the most regressive anti-reproductive health care budget in New Hampshire history, ignoring public opinion and opposition from more than 200 of the state’s leading medical experts," according to a recent release from Planned Parenthood.

The law is slated to take effect in January 2022. Get Cass' take on what this means for providers.

Recent Videos
HPV self-collection: Benefits, limitations, and future implications | Image Credit: forhers.com
Improving pediatric HPV vaccination rates: Early initiation and addressing disparities | Image Credit: blog.nemours.org.
New cervical cancer screening guidelines: What practitioners needs to know | Image Credit: forhers.com
COVID-19 Therapy Roundtable: Focusing on inpatient care
COVID-19 Therapy Roundtable: Defining the virus today and treatment options
How fezolinetant advances non-hormonal treatment of hot flashes | Image Credit: medschool.cuanschutz.edu
Contraceptive access challenges for college students in contraception deserts | Image Credit: linkedin.com.
Kameelah Phillips, MD, FACOG, NCMP, is featured in this series.
Related Content
Study reports medical abortion pain higher than expectations | Image Credit: © Vlyaks - © Vlyaks - stock.adobe.com.

Study reports medical abortion pain higher than expectations

Celeste Krewson, Assistant Editor
December 24th 2024
Article

New research reveals that nearly half of women experience more pain than expected during medical abortion, highlighting the need for improved pain management counseling.

Read More

Site Logo

How Individually Identifying More HPV Types Enables Better Patient Management and More Precise Care

September 29th 2023
Podcast

Listen

FDA reports no contaminant exposure from tampon use | Image Credit: © Tada Images - © Tada Images - stock.adobe.com.

FDA reports no contaminant exposure from tampon use

Celeste Krewson, Assistant Editor
Published: December 23rd 2024 | Updated: December 24th 2024
Article

In a recent literature reveal, no significant changes in biomarker concentrations for metal exposure were reported in patients using tampon vs non-tampon users.

Read More

Site Logo

The Importance of Including Hemoglobinopathies as a Part of Carrier Screening Panels

September 15th 2023
Podcast

Listen

New guidelines aim to revolutionize POI diagnosis and management | Image Credit: © Kzenon - © Kzenon - stock.adobe.com.

New guidelines aim to revolutionize POI diagnosis and management

Celeste Krewson, Assistant Editor
December 20th 2024
Article

New evidence-based recommendations provide a clearer pathway for diagnosing and treating premature ovarian insufficiency, improving outcomes for women worldwide.

Read More

Contemporary OB/GYN week in review: Avian influenza, US health rankings, and more | Image Credit: © Aleksey 159 - © Aleksey 159 - stock.adobe.com.

Contemporary OB/GYN week in review: Avian influenza, US health rankings, and more

Celeste Krewson, Assistant Editor
December 20th 2024
Article

Review some of the top stories from the Contemporary OB/GYN website over the last week, and catch up on anything you may have missed.

Read More

© 2024 MJH Life Sciences

All rights reserved.